COVID Update: With J&J’s Return, Belmont Resumes Homebound Vaccinations

Photo: The latest update on the COVID-19 virus in Belmont

Three days after the CDC and the U.S. Food and Drug Administration approved the resumption of the Johnson & Johnson vaccine in the general public, the Massachusetts Department of Health gave the “green light” for Belmont’s Health Department to resume its homebound vaccination effort, according to Wesley Chin, director of Belmont’s Health Department.

Speaking before the Select Board at its Monday, April 26 meeting, Chin said the town has vaccinated 46 at home residents with the help of the Belmont Fire Department.

“I just to encourage any residents out there who are homebound, please call our office at 617-993-2720 and we can schedule an appointment to get them vaccinated in their home,” said Chin.

As of the latest data, 80 percent of residents 75 and older have been fully vaccinated. A third of all residents have had their two shots with 55 percent of the population having at least one vaccine jab.

The temporary halt of the J&J vaccine came after reports of adverse effects primarily an increased risk of blood clots with low platelets in adult women younger than 50 years old. It was resumed after the government said the vaccine’s known and potential benefits outweigh its potential risks.

According to the Health Department, as of April 23, Belmont has 1,106 cumulative confirmed cases of COVID-19, an increase of 10 cases since April 16. There have been a total of 80 COVID-19 related deaths to date, all of which are confirmed by filed death certificates with the Town Clerk’s Office. 

Due to the new case count over the past two weeks, Belmont’s average daily incidence of 8.1 per 100,000, and the .90 percent positivity, Belmont remains “green” according to the state’s color designation metrics.

Share This ArticleShare on FacebookTweet about this on TwitterShare on Google+Pin on PinterestShare on LinkedInPrint this pageEmail this to someone

Leave a Review or Comment

Your email address will not be published.